A GAO report examines the "extraordinary" price increases of brand-name drugs. Some of these increases are very, very large, but many are made by repackagers, not the original manufacturer. Many…
Read More
http://www.washingtonpost.com/wp-dyn/content/article/2010/01/11/AR2010011102231.html